Introduction
Methods
Patients
Neuroimaging
Classification of acute stroke
Statistical analysis
Results
Odds ratio | 95% confidence interval |
P
| |
---|---|---|---|
TOAST classification | |||
LAA vs. SUE | 1.011 | 0.248–4.117 | 0.988 |
SAA vs. SUE | 0.383 | 0.121–1.214 | 0.103 |
CE vs. SUE | – | – | – |
SOE vs. SUE | 1.386 | 0.470–3.517 | 0.625 |
Hypertension history | 1.843 | 0.664–5.119 | 0.241 |
Hypertension classification | 1.233 | 0.887–1.713 | 0.212 |
SBP | 1.000 | 0.983–1.018 | 0.969 |
DBP | 0.998 | 0.966–1.032 | 0.927 |
Diabetes | 1.415 | 0.675–2.967 | 0.358 |
Fasting blood glucose | 1.039 | 0.901–1.196 | 0.600 |
HbA1c | 1.164 | 0.969–1.400 | 0.105 |
LDL | 0.511 | 0.313–0.836 | 0.008 |
HDL | 0.623 | 0.155–2.507 | 0.505 |
TC | 0.498 | 0.318–0.778 | 0.002 |
TG | 1.006 | 0.616–1.642 | 0.980 |
Uric acid | 1.003 | 0.999–1.007 | 0.100 |
Creatinine | 1.011 | 0.997–1.025 | 0.133 |
Microbleeds | 7.000 | 2.742–17.867 | <0.001 |
Microbleeds score | 1.062 | 1.006–1.121 | 0.030 |
Hemorrhagic transformation | 0.265 | 0.034–2.078 | 0.206 |
Prominent vessel sign on SWI | 3.086 | 0.841–11.328 | 0.089 |
History of antithrombotic drugs | 3.143 | 1.176–8.400 | 0.022 |
Brain white matter degeneration score | 1.357 | 1.090–1.690 | 0.006 |
Odds ratio | 95% confidence interval |
P
| |
---|---|---|---|
Total cholesterol | 0.510 | 0.312–0.832 | 0.007 |
Cerebral microbleeds | 6.251 | 2.220–17.601 | 0.001 |
Use history of antithrombotic drugs | 3.213 | 1.018–10.145 | 0.047 |